Abstract P5-06-09: Rivaroxaban targets the procoagulant tumour microenvironment in vitro and thereby inhibits breast cancer progression

Authors: Emma L Blower, John Castle, Angelica Santiago-Gomez, Robert Clarke, Cliona C Kirwan

Published: 2022-03-08

DOI: 10.1158/1538-7445.sabcs21-p5-06-09

Source: Full article